Tommie Reerink

Stock Analyst at Goldman Sachs

(2.07)
# 2,755
Out of 4,786 analysts
3
Total ratings
66.67%
Success rate
2.7%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Tommie Reerink

Atara Biotherapeutics
Jul 17, 2024
Maintains: Sell
Price Target: $13$11
Current: $5.94
Upside: +85.19%